Table 3.

Serious adverse reactions in a pooled gBRCAm population

Three or more lines of prior chemotherapy
Serious adverse reactionN = 223 (%)
Patients with any serious adverse reaction35
Blood and lymphatic system disorders
 Anemia5
 Neutropenia/febrile neutropenia/leukopenia2
Gastrointestinal disorders
 Bowel obstruction9
 Abdominal pain4
 Nausea and vomiting4
Infections and infestations
 Sepsis/infection3